| Controls | PCOS | ||
---|---|---|---|---|
AA (n = 379) | AG + GG (n = 121 + 6) | AA (n = 435) | AG + GG (n = 134 + 6) | |
Age (yr) | 28.18 ± 4.10 | 27.28 ± 4.41a | 24.68 ± 4.01a, b | 24.60 ± 3.81a, b |
BMI (kg/m2) | 21.17 ± 2.96 | 20.88 ± 2.74 | 23.24 ± 4.32a, b | 22.68 ± 4.03a, b |
Waist circumference (cm) | 73.41 ± 8.21 | 73.36 ± 8.36 | 80.13 ± 11.67a, b | 77.96 ± 11.22a, b |
Waist-to-hip ratio | 0.81 ± 0.06 | 0.82 ± 0.06 | 0.86 ± 0.07a, b | 0.84 ± 0.07a, b |
F-G score | 0.22 ± 0.69 | 0.26 ± 0.82 | 1.73 ± 2.07a, b | 1.71 ± 2.08a, b |
Acne grade score | 0.10 ± 0.30 | 0.08 ± 0.27 | 0.66 ± 0.94a, b | 0.53 ± 0.86a, b |
SBP (mmHg) | 113.42 ± 11.55 | 112.98 ± 11.84 | 114.89 ± 10.42a | 113.78 ± 11.65 |
DBP (mmHg) | 73.97 ± 8.88 | 73.40 ± 8.75 | 76.35 ± 9.08a, b | 74.70 ± 8.99 |
Ovarian volume (ml) | 7.88 ± 2.76 | 7.47 ± 3.24 | 10.22 ± 3.92a, b | 9.95 ± 4.63a, b |
Hormonal levels | ||||
E2 (pmol/L) | 322.08 ± 341.61 | 367.37 ± 376.94 | 281.07 ± 279.42b | 293.07 ± 245.85 |
TT (nmol/L) | 1.54 ± 0.54 | 1.53 ± 0.56 | 2.41 ± 0.77a, b | 2.45 ± 0.77a, b |
LH (IU/L) | 8.53 ± 10.38 | 9.28 ± 13.76 | 13.24 ± 8.57a, b | 15.85 ± 15.91a, b, c |
FSH (IU/L) | 6.59 ± 2.84 | 6.89 ± 3.34 | 5.95 ± 2.27a, b | 6.12 ± 2.11b |
LH/FSH | 1.31 ± 1.24 | 1.29 ± 1.54 | 2.28 ± 1.18a, b | 2.58 ± 1.45a, b |
Metabolic profile | ||||
Fasting Ins (pmol/L) | 64.87 ± 32.78 | 73.28 ± 46.17a | 109.10 ± 77.82a, b | 96.60 ± 60.98a, b |
Fasting Glu (mmol/L) | 5.26 ± 0.46 | 5.42 ± 1.22a | 5.38 ± 0.71a | 5.36 ± 0.93a |
HOMA-IR | 2.22 ± 1.22 | 2.73 ± 3.13a | 3.89 ± 3.31a, b | 3.46 ± 2.80a, b |
TG (mmol/L) | 1.02 ± 0.93 | 1.08 ± 0.76 | 1.46 ± 1.50a, b | 1.29 ± 0.73a |
TC (mmol/L) | 4.22 ± 0.71 | 4.31 ± 0.66 | 4.35 ± 0.80a | 4.57 ± 0.82a, b, c |
HDL-C (mmol/L) | 1.52 ± 0.32 | 1.48 ± 0.29 | 1.37 ± 0.34a, b | 1.42 ± 0.36a, b |
LDL-C (mmol/L) | 2.32 ± 0.61 | 2.44 ± 0.60 | 2.51 ± 0.75a | 2.66 ± 0.77a, b, c |
non-HDL-C (mmol/L) | 2.70 ± 0.63 | 2.83 ± 0.65 | 2.98 ± 0.81a, b | 3.14 ± 0.78a, b, c |
AI | 1.87 ± 0.65 | 2.02 ± 0.74a | 2.37 ± 1.05a, b | 2.37 ± 0.91a, b |
ApoA1 (g/L) | 1.46 ± 0.22 | 1.44 ± 0.18 | 1.41 ± 0.21a | 1.43 ± 0.22a |
ApoB (g/L) | 0.74 ± 0.17 | 0.78 ± 0.17a | 0.81 ± 0.20a, b | 0.85 ± 0.20a, b, c |
ApoB/apoA1 | 0.52 ± 0.14 | 0.55 ± 0.16a | 0.59 ± 0.18a, b | 0.61 ± 0.19a, b, c |
PAF-AH activityd | ||||
Plasma PAF-AH (nmol/min/ml) | 47.80 ± 10.91 | 50.08 ± 10.39a | 47.54 ± 12.27b | 47.05 ± 15.17 |
H-PAF-AH (nmol/min/ml) | 5.09 ± 1.51 | 5.30 ± 1.52 | 4.64 ± 1.89a, b | 4.77 ± 2.01 |
ApoB-PAF-AH (nmol/min/ml) | 42.74 ± 10.09 | 44.78 ± 9.50a | 42.91 ± 11.34 | 42.28 ± 13.74 |
ApoB-PAF-AH/H-PAF-AH | 8.85 ± 2.61 | 8.88 ± 2.09 | 10.91 ± 4.17a, b | 9.48 ± 2.60 |